KPTI vs TTWO · rev $68.5M vs rev $6.66B
Karyopharm Therapeutics Inc (KPTI) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
KPTI currently screens at market cap $205.6M. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the KPTI and TTWO stock pages for the full models.
Not investment advice.